Good news, if you don't get to here you go nowhere...
This is very interesting....
FDA have agreed to test 90mg efti dosing in combination with paclitaxel driven predominantly by the excellent
safety profile of the AIPAC Phase IIb trial, along with the FDA’s Project Optimus initiative in oncology.
Presumably, the higher the dose the quicker the response......shows the unmet need importance in regard
to FDA discussions...seems like upping the dose was an immutep iniative.....good signs here..
Ann: Update on MBC trial design following successful FDA meeting, page-4
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
0.005(1.25%) |
Mkt cap ! $588.3M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.5¢ | 39.8¢ | $2.431M | 6.045M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6880 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 85353 | 3 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |